Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Eric Linsley to speak at CED's Biotech Forum: "How Early is Too Early?" in RTP, NC
News | 04. 28. 2008
